GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » MicroPort NeuroTech Ltd (HKSE:02172) » Definitions » EV-to-EBITDA

MicroPort NeuroTech (HKSE:02172) EV-to-EBITDA : 21.91 (As of Jun. 05, 2024)


View and export this data going back to 2022. Start your Free Trial

What is MicroPort NeuroTech EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, MicroPort NeuroTech's enterprise value is HK$3,966.8 Mil. MicroPort NeuroTech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$181.0 Mil. Therefore, MicroPort NeuroTech's EV-to-EBITDA for today is 21.91.

The historical rank and industry rank for MicroPort NeuroTech's EV-to-EBITDA or its related term are showing as below:

HKSE:02172' s EV-to-EBITDA Range Over the Past 10 Years
Min: 15.47   Med: 34.05   Max: 109.02
Current: 21.33

During the past 5 years, the highest EV-to-EBITDA of MicroPort NeuroTech was 109.02. The lowest was 15.47. And the median was 34.05.

HKSE:02172's EV-to-EBITDA is ranked worse than
69.98% of 483 companies
in the Medical Devices & Instruments industry
Industry Median: 15.89 vs HKSE:02172: 21.33

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-05), MicroPort NeuroTech's stock price is HK$8.59. MicroPort NeuroTech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.273. Therefore, MicroPort NeuroTech's PE Ratio for today is 31.47.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


MicroPort NeuroTech EV-to-EBITDA Historical Data

The historical data trend for MicroPort NeuroTech's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MicroPort NeuroTech EV-to-EBITDA Chart

MicroPort NeuroTech Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBITDA
- - - 72.39 25.18

MicroPort NeuroTech Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial - - 72.39 - 25.18

Competitive Comparison of MicroPort NeuroTech's EV-to-EBITDA

For the Medical Devices subindustry, MicroPort NeuroTech's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MicroPort NeuroTech's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, MicroPort NeuroTech's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MicroPort NeuroTech's EV-to-EBITDA falls into.



MicroPort NeuroTech EV-to-EBITDA Calculation

MicroPort NeuroTech's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=3966.828/181.033
=21.91

MicroPort NeuroTech's current Enterprise Value is HK$3,966.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MicroPort NeuroTech's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was HK$181.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


MicroPort NeuroTech  (HKSE:02172) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

MicroPort NeuroTech's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=8.59/0.273
=31.47

MicroPort NeuroTech's share price for today is HK$8.59.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. MicroPort NeuroTech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$0.273.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


MicroPort NeuroTech EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MicroPort NeuroTech's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


MicroPort NeuroTech (HKSE:02172) Business Description

Traded in Other Exchanges
N/A
Address
No. 1661 Zhangdong Road, Pudong New Area, Shanghai, CHN
MicroPort NeuroTech Ltd is into the neuro-interventional medical device industry, dedicated to providing innovative solutions for physicians and patients. The company boast a comprehensive portfolio of approved therapeutic products covering all of the three main areas of neurovascular disease, namely hemorrhagic stroke, cerebral atherosclerotic stenosis and acute ischemic stroke.
Executives
Hu Yibin
Biolink Biomedical Ltd. 2201 Interest of corporation controlled by you
Blossom Vision Limited 2201 Interest of corporation controlled by you
Lion Fish Limited 2201 Interest of corporation controlled by you
Suntera Corporate Trustees (hong Kong) Limited 2301 Trustee
Thriving Hope Limited 2201 Interest of corporation controlled by you
Biolink Fund Limited Partnership 2201 Interest of corporation controlled by you
Biolink Limited 2101 Beneficial owner
Microport Scientific Corporation
Microport Scientific Investment Ltd
Maxwell Maxcare Science Foundation Limited
We'tron Capital Limited

MicroPort NeuroTech (HKSE:02172) Headlines

No Headlines